Six-year vitamin E supplementation increased tuberculosis risk by 72% in male smokers who had high dietary vitamin C intake, but vitamin E had no effect on those who had low dietary vitamin C intake, according to a study published in the British Journal of Nutrition.
Previous studies had suggested that vitamin E might improve the immune system. In animal studies vitamin E seemed to protect against various infections.
Harri Hemila and Jaakko Kaprio, of the University of Helsinki, Helsinki, Finland, studied whether vitamin E supplementation might decrease the risk of tuberculosis. They analyzed the data of the randomized trial (Alpha-Tocopherol Beta-Carotene Cancer Prevention Study) which was conducted in Finland between 1985-1993 and included male smokers aged 50-69 years. There were 174 cases of tuberculosis in 29,023 participants during the 6-year supplementation of 50 mg/day vitamin E.
The effect of vitamin E on tuberculosis risk was modified by the intake of vitamin C in diet. Vitamin E had no effect on participants who had dietary vitamin C intake less than 90 mg/day. Unexpectedly, vitamin E supplementation increased tuberculosis risk by 72% in those who had dietary vitamin C intake over 90 mg/day. The most dramatic increase in tuberculosis risk by vitamin E was restricted to a one-year period after the initiation of supplementation.
The US nutritional recommendations, issued by the prestigious Institute of Medicine, consider that vitamin E is safe in amounts up to 1000 mg/day. This new study suggests that in some population groups vitamin E supplementation may be harmful at a substantially lower dose, 50 mg/day.
The researchers concluded that the consumption of vitamin E supplements by the general population should be discouraged because there is evidence of harm for some people.
Source: University of Helsinki
Related stories:
Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence
New findings show a link between micronutrient supplementation and reduced risk of recurrence during tuberculosis chemotherapy, according to a study published in the June 1 issue of
The Journal of Infectious Diseases, now available online.
Scientists test device to track medication adherence in patients with HIV/AIDS
Most of us have missed a dose of antibiotic or forgotten to take a daily vitamin. But when the stakes are higher as they are for people with HIV/AIDS a skipped pill could mean the difference between health and hazard for the entire population.
Study shows effects of vitamin D and skin's physiology
Researchers from Boston University School of Medicine (BUSM) have found that previtamin D3 production varies depending on several factors including skin type and weather conditions. The study will appear in the March 2008 issue of the
Journal of Bone and Mineral Research.
Vitamin D supplements may offer cheap and effective immune system boost against TB
Scientists have shown that a single 2.5mg dose of vitamin D may be enough to boost the immune system to fight against tuberculosis (TB) and similar bacteria for at least 6 weeks. Their findings came from a study that identified an extraordinarily high incidence of vitamin D deficiency amongst those communities in London most at risk from the disease, which kills around two million people each year.
Low vitamin D levels linked to poor physical performance in older adults
Older adults who don't get enough vitamin D either from their diets or exposure to the sun may be at increased risk for poor physical performance and disability, according to new research from Wake Forest University School of Medicine and colleagues.
Tips on getting vitamin D for cancer prevention
(AP) --
Evidence is growing that vitamin D, which the skin makes from sunshine, is linked to lower risk of breast cancer and other cancers. But that doesn't mean it's good to get a golden tan - and certainly not a sunburn.
Researchers show link between vitamin D status, breast cancer
Using newly available data on worldwide cancer incidence, researchers at the Moores Cancer Center at University of California, San Diego and the Department of Family and Preventive Medicine have shown a clear association between deficiency in exposure to sunlight, specifically ultraviolet B (UVB), and breast cancer.
Drug therapy for PKU reverses heart damage
A pricy drug used to treat a rare but well-known genetic disorder may hold wider promise as a treatment for millions of Americans with potentially lethal enlarged hearts, due mainly to high blood pressure, a study from Johns Hopkins shows.